Company & Sponsor Intelligence
Massachusetts General Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials97
Recruiting17
Completed57
Countries2
Therapeutic footprint
adhdalsalzheimersanxietyautismbipolar_disorderdementia_otherdepressionepilepsyhuntingtonsneurodevelopmental_otherother_neurologyother_psychiatrypain_neuropathyparkinsonsptsdschizophreniastrokesubstance_usetraumatic_brain_injury
Indexed studies
NCT01506232Brain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary Study
autism · United StatesTERMINATED
autism · United StatesTERMINATED
NCT03118752Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety
depression · United StatesNA
depression · United StatesNA
NCT00711724Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD
adhd · United StatesCOMPLETED
adhd · United StatesCOMPLETED
NCT03537261CPI Training for Parents of Children With ASD
autism · United StatesNA
autism · United StatesNA
NCT05195684MGH Trauma-related Nightmares SDI Study
ptsd · United StatesNA
ptsd · United StatesNA
NCT01724476A Trial of Folate With B12 in Patients With Schizophrenia With Residual Symptoms in Ethiopia
schizophrenia · EthiopiaPHASE4
schizophrenia · EthiopiaPHASE4
NCT01786174Gilenya in Amyotrophic Lateral Sclerosis (ALS)
als · United StatesPHASE2
als · United StatesPHASE2
NCT01312844A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
depression · United StatesPHASE2
depression · United StatesPHASE2
NCT01873729An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
adhd · United StatesPHASE4
adhd · United StatesPHASE4
NCT07417137A Natural History Study of Angelman Syndrome
neurodevelopmental_other · United StatesRECRUITING
neurodevelopmental_other · United StatesRECRUITING
NCT05336695Assess Fibrin in Brains With AD/ADRD
alzheimers · United StatesPHASE1, PHASE2
alzheimers · United StatesPHASE1, PHASE2
NCT01932541Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
bipolar_disorder · United StatesPHASE4
bipolar_disorder · United StatesPHASE4
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →